{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,13]],"date-time":"2026-06-13T07:55:43Z","timestamp":1781337343528,"version":"3.54.1"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,6,13]]},"DOI":"10.7759\/cureus.110762","type":"journal-article","created":{"date-parts":[[2026,6,13]],"date-time":"2026-06-13T07:13:30Z","timestamp":1781334810000},"source":"Crossref","is-referenced-by-count":0,"title":["Biological Profile of Dysmyelopoiesis in Bone Marrow Aspirates at the Joseph Ravoahangy Andrianavalona University Hospital, Madagascar"],"prefix":"10.7759","author":[{"given":"Stephania","family":"Niry Manantsoa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jocia","family":"Fenomanana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tchesterico B","family":"Dodoson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Volamahefa","family":"Randriambola","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andriamiadana L","family":"Rakotovao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aim\u00e9e Olivat","family":"Rakoto Alson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2011.056879","article-title":"Assessment of dysplastic hematopoiesis: lessons from healthy bone marrow donors","volume":"97","author":"Parmentier S","year":"2012","unstructured":"Parmentier S, Schetelig J, Lorenz K, et al.. Assessment of dysplastic hematopoiesis: lessons from healthy bone marrow donors. Haematologica. 2012, 97:723-30. 10.3324\/haematol.2011.056879","journal-title":"Haematologica"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.2174\/1871529x15666150701105822","article-title":"Evaluation of a bone marrow Dysmyelopoiesis Immunophenotypic Index for the diagnosis and prognosis of myelodysplastic syndromes","volume":"15","author":"Verigou E","year":"2015","unstructured":"Verigou E, Lampropoulou P, Smyrni N, et al.. Evaluation of a bone marrow Dysmyelopoiesis Immunophenotypic Index for the diagnosis and prognosis of myelodysplastic syndromes. Cardiovasc Hematol Disord Drug Targets. 2015, 15:148-61. 10.2174\/1871529x15666150701105822","journal-title":"Cardiovasc Hematol Disord Drug Targets"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.26984","article-title":"Myelodysplastic syndromes: 2023 update on diagnosis, risk-stratification, and management","volume":"98","author":"Garcia-Manero G","year":"2023","unstructured":"Garcia-Manero G. Myelodysplastic syndromes: 2023 update on diagnosis, risk-stratification, and management. Am J Hematol. 2023, 98:1307-25. 10.1002\/ajh.26984","journal-title":"Am J Hematol"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2022.14578","article-title":"Diagnosis and treatment of myelodysplastic syndromes: a review","volume":"328","author":"Sekeres MA","year":"2022","unstructured":"Sekeres MA, Taylor J. Diagnosis and treatment of myelodysplastic syndromes: a review. JAMA. 2022, 328:872-80. 10.1001\/jama.2022.14578","journal-title":"JAMA"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2012.071449","article-title":"Reproducibility of the World Health Organization 2008 criteria for myelodysplastic syndromes","volume":"98","author":"Senent L","year":"2013","unstructured":"Senent L, Arenillas L, Lu\u00f1o E, Ruiz JC, Sanz G, Florensa L. Reproducibility of the World Health Organization 2008 criteria for myelodysplastic syndromes. Haematologica. 2013, 98:568-75. 10.3324\/haematol.2012.071449","journal-title":"Haematologica"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1111\/j.1751-553X.2008.01100.x","article-title":"ICSH guidelines for the standardization of bone marrow specimens and reports","volume":"30","author":"Lee SH","year":"2008","unstructured":"Lee SH, Erber WN, Porwit A, Tomonaga M, Peterson LC. ICSH guidelines for the standardization of bone marrow specimens and reports. Int J Lab Hematol. 2008, 30:349-64. 10.1111\/j.1751-553X.2008.01100.x","journal-title":"Int J Lab Hematol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2023.284937","article-title":"Diagnosis of myelodysplastic syndromes: the classic and the novel","volume":"110","author":"Oster HS","year":"2025","unstructured":"Oster HS, Van de Loosdrecht AA, Mittelman M. Diagnosis of myelodysplastic syndromes: the classic and the novel. Haematologica. 2025, 110:300-11. 10.3324\/haematol.2023.284937","journal-title":"Haematologica"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2012-03-420489","article-title":"Revised international prognostic scoring system for myelodysplastic syndromes","volume":"120","author":"Greenberg PL","year":"2012","unstructured":"Greenberg PL, Tuechler H, Schanz J, et al.. Revised international prognostic scoring system for myelodysplastic syndromes. Blood. 2012, 120:2454-65. 10.1182\/blood-2012-03-420489","journal-title":"Blood"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2016-03-643544","article-title":"The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia","volume":"127","author":"Arber DA","year":"2016","unstructured":"Arber DA, Orazi A, Hasserjian R, et al.. The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia. Blood. 2016, 127:2391-2405. 10.1182\/blood-2016-03-643544","journal-title":"Blood"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1002\/jgf2.31","article-title":"Diagnosis and treatment of macrocytic anemias in adults","volume":"18","author":"Nagao T","year":"2017","unstructured":"Nagao T, Hirokawa M. Diagnosis and treatment of macrocytic anemias in adults. J Gen Fam Med. 2017, 18:200-4. 10.1002\/jgf2.31","journal-title":"J Gen Fam Med"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1159\/000489702","article-title":"Myelodysplastic syndrome updated","volume":"86","author":"Hasserjian RP","year":"2019","unstructured":"Hasserjian RP. Myelodysplastic syndrome updated. Pathobiology. 2019, 86:7-13. 10.1159\/000489702","journal-title":"Pathobiology"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.3390\/diagnostics12071698","article-title":"Perls' stain guidelines from the French-Speaking Cellular Hematology Group (GFHC)","volume":"12","author":"Lours C","year":"2022","unstructured":"Lours C, Cottin L, Wiber M, et al.. Perls' stain guidelines from the French-Speaking Cellular Hematology Group (GFHC). Diagnostics (Basel). 2022, 12:1698. 10.3390\/diagnostics12071698","journal-title":"Diagnostics (Basel)"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-022-22340-8","article-title":"Fold-change of chromatin condensation in yeast is a conserved property","volume":"12","author":"Yamin K","year":"2022","unstructured":"Yamin K, Bijlani S, Berman J, et al.. Fold-change of chromatin condensation in yeast is a conserved property. Sci Rep. 2022, 12:17393. 10.1038\/s41598-022-22340-8","journal-title":"Sci Rep"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1152\/physrev.00012.2018","article-title":"The neutrophil's role during health and disease","volume":"99","author":"Liew PX","year":"2019","unstructured":"Liew PX, Kubes P. The neutrophil's role during health and disease. Physiol Rev. 2019, 99:1223-48. 10.1152\/physrev.00012.2018","journal-title":"Physiol Rev"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1038\/s41375-018-0029-9","article-title":"A decade of progress in myelodysplastic syndrome with chromosome 5q deletion","volume":"32","author":"List A","year":"2018","unstructured":"List A, Ebert BL, Fenaux P. A decade of progress in myelodysplastic syndrome with chromosome 5q deletion. Leukemia. 2018, 32:1493-9. 10.1038\/s41375-018-0029-9","journal-title":"Leukemia"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.3390\/jcm14082681","article-title":"The role of megakaryocyte assessment in bone marrow cytology","volume":"14","author":"B\u0142ocka-Gumowska M","year":"2025","unstructured":"B\u0142ocka-Gumowska M, Hus I, Szymczyk A. The role of megakaryocyte assessment in bone marrow cytology. J Clin Med. 2025, 14:2681. 10.3390\/jcm14082681","journal-title":"J Clin Med"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1111\/ejh.13134","article-title":"Can bone marrow cellularity help in predicting prognosis in myelodysplastic syndromes?","volume":"101","author":"Greenbaum U","year":"2018","unstructured":"Greenbaum U, Joffe E, Filanovsky K, et al.. Can bone marrow cellularity help in predicting prognosis in myelodysplastic syndromes?. Eur J Haematol. 2018, 101:502-7. 10.1111\/ejh.13134","journal-title":"Eur J Haematol"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1007\/s11912-021-01136-5","article-title":"Is myelodysplasia a consequence of normal aging?","volume":"23","author":"Heibl S","year":"2021","unstructured":"Heibl S, Stauder R, Pfeilst\u00f6cker M. Is myelodysplasia a consequence of normal aging?. Curr Oncol Rep. 2021, 23:142. 10.1007\/s11912-021-01136-5","journal-title":"Curr Oncol Rep"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2023.283661","article-title":"Patterns of lower risk myelodysplastic syndrome progression: factors predicting progression to high-risk myelodysplastic syndrome and acute myeloid leukemia","volume":"109","author":"Jain AG","year":"2024","unstructured":"Jain AG, Ball S, Aguirre L, et al.. Patterns of lower risk myelodysplastic syndrome progression: factors predicting progression to high-risk myelodysplastic syndrome and acute myeloid leukemia. Haematologica. 2024, 109:2157-64. 10.3324\/haematol.2023.283661","journal-title":"Haematologica"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1016\/S2352-3026(15)00067-8","article-title":"Use of newer prognostic indices for patients with myelodysplastic syndromes in the low and intermediate-1 risk categories: a population-based study","volume":"2","author":"Valc\u00e1rcel D","year":"2015","unstructured":"Valc\u00e1rcel D, Sanz G, Ortega M, et al.. Use of newer prognostic indices for patients with myelodysplastic syndromes in the low and intermediate-1 risk categories: a population-based study. Lancet Haematol. 2015, 2:E260-6. 10.1016\/S2352-3026(15)00067-8","journal-title":"Lancet Haematol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/498138-biological-profile-of-dysmyelopoiesis-in-bone-marrow-aspirates-at-the-joseph-ravoahangy-andrianavalona-university-hospital-madagascar","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,13]],"date-time":"2026-06-13T07:13:31Z","timestamp":1781334811000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/498138-biological-profile-of-dysmyelopoiesis-in-bone-marrow-aspirates-at-the-joseph-ravoahangy-andrianavalona-university-hospital-madagascar"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,13]]},"references-count":20,"URL":"https:\/\/doi.org\/10.7759\/cureus.110762","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6,13]]}}}